By this, the study identifies only few shared mutations, respective exact sequence variants throughout the disease course of individual colorectal cancer patients, including KRAS and NRAS. Furthermore, the study shows case-matched de novo altered mutation profiles in synchronous vs metachrounous liver and/or lung metastasis. This evidence concerns the gene KRAS and colorectal cancer.